XML 42 R31.htm IDEA: XBRL DOCUMENT v3.23.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
 12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
SCHEDULE OF REVENUE DISAGGREGATED BY SERVICES AND PRODUCTS

The following table contains revenues as presented in the consolidated statements of operations disaggregated by services and products.

 

SCHEDULE OF REVENUE DISAGGREGATED BY SERVICES AND PRODUCTS

   For the Year Ended December 31, 2022   For the Year Ended December 31, 2021 
Regenerative Medicine Products          
SkinTE Products  $–   $3,076 
           
Contract Services          
Lab Testing Services   –    1,877 
Preclinical Research Services   814    4,451 
    814    6,328 
Total Net Revenues  $814   $9,404